STOLFO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 9.778
EU - Europa 8.059
AS - Asia 6.770
SA - Sud America 966
AF - Africa 232
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 12
Totale 25.837
Nazione #
US - Stati Uniti d'America 9.546
IT - Italia 3.435
SG - Singapore 2.582
CN - Cina 1.624
PL - Polonia 1.097
VN - Vietnam 745
BR - Brasile 723
HK - Hong Kong 638
DE - Germania 564
SE - Svezia 546
FR - Francia 404
KR - Corea 356
NL - Olanda 353
GB - Regno Unito 318
RU - Federazione Russa 298
FI - Finlandia 241
IN - India 180
UA - Ucraina 135
IE - Irlanda 132
BG - Bulgaria 127
CA - Canada 109
TR - Turchia 86
JP - Giappone 83
MX - Messico 82
AT - Austria 78
AR - Argentina 74
BD - Bangladesh 65
MA - Marocco 64
ES - Italia 60
ZA - Sudafrica 53
ID - Indonesia 52
CH - Svizzera 48
IQ - Iraq 48
PK - Pakistan 45
BE - Belgio 43
EC - Ecuador 35
CO - Colombia 33
GR - Grecia 30
SA - Arabia Saudita 30
VE - Venezuela 29
RO - Romania 27
CL - Cile 26
SN - Senegal 25
EG - Egitto 24
IR - Iran 24
PE - Perù 24
UZ - Uzbekistan 21
AE - Emirati Arabi Uniti 20
PH - Filippine 18
AU - Australia 17
DZ - Algeria 16
PT - Portogallo 15
JO - Giordania 14
MY - Malesia 14
NP - Nepal 14
CZ - Repubblica Ceca 13
LT - Lituania 13
TW - Taiwan 13
HU - Ungheria 11
IL - Israele 11
OM - Oman 11
TH - Thailandia 11
KE - Kenya 10
KZ - Kazakistan 10
PY - Paraguay 10
CR - Costa Rica 9
LV - Lettonia 9
TN - Tunisia 9
AL - Albania 8
AZ - Azerbaigian 8
DK - Danimarca 8
RS - Serbia 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
EU - Europa 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
JM - Giamaica 6
NO - Norvegia 6
BH - Bahrain 5
BY - Bielorussia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TG - Togo 4
CG - Congo 3
CY - Cipro 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
Totale 25.790
Città #
Singapore 1.521
Ashburn 1.378
Warsaw 938
Fairfield 779
Chandler 745
San Jose 632
Hong Kong 614
Woodbridge 464
Trieste 416
Houston 374
Beijing 361
Seoul 343
Hefei 335
Seattle 333
Ann Arbor 319
Milan 311
Wilmington 286
Cambridge 245
Rome 231
Ho Chi Minh City 217
Los Angeles 213
Chicago 207
Boardman 202
Dallas 183
Princeton 165
Council Bluffs 164
Hanoi 157
Naples 156
Lauterbourg 146
Helsinki 138
London 138
Santa Clara 137
Sofia 125
Columbus 123
Jacksonville 123
Dublin 119
Zgierz 119
New York 114
Frankfurt am Main 108
Moscow 107
The Dalles 97
São Paulo 89
Munich 85
Turin 67
Buffalo 64
Dearborn 62
Amsterdam 61
Tokyo 56
Düsseldorf 53
Izmir 47
Bologna 46
Florence 46
Vienna 45
Grafing 44
Orem 44
Nuremberg 43
San Diego 43
Casablanca 42
Da Nang 42
Lappeenranta 42
Denver 41
Guangzhou 40
Brussels 39
Phoenix 39
Shanghai 39
Toronto 39
Atlanta 38
Genoa 38
Catania 37
Montreal 35
Palermo 35
Washington 35
Chennai 34
Padova 34
Bari 32
Bremen 32
Haiphong 32
Turku 32
Nanjing 29
Redondo Beach 29
Rio de Janeiro 29
Venice 29
Dong Ket 28
Udine 28
Brooklyn 27
Verona 27
Dakar 25
Des Moines 25
Jinan 25
Johannesburg 25
Mykolayiv 25
Pune 25
Redmond 25
Mumbai 24
Redwood City 24
Bern 23
Stockholm 23
Treviso 23
Wroclaw 23
Mexico City 21
Totale 16.117
Nome #
Linee guida sullo scompenso cardiaco a confronto: AHA 2022 versus ESC 2021 1.982
Cardiac fluid dynamics meets deformation imaging 466
Natural History of Dilated Cardiomyopathy in Children 428
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 402
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 384
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 336
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 316
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 309
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking 295
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 271
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 270
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 264
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 260
Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome 258
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 256
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 255
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 255
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 252
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 251
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 248
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 247
Chapter 12: Prognostic Stratification and Importance of Follow-Up 243
Treatment of Functional Mitral Regurgitation in Heart Failure 242
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 240
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 240
Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure 239
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 239
Impact of patient delay in a modern real world STEMI network 235
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 235
Evolving concepts in dilated cardiomyopathy 234
Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature 231
ECG in dilated cardiomyopathy: Specific findings and long-term prognostic significance 230
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 229
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 225
Prevalence and prognostic significance of ischemic late gadolinium enhancement pattern in non-ischemic dilated cardiomyopathy 224
Left Atrial Reverse Remodeling in Dilated Cardiomyopathy 222
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 217
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 216
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 216
Chapter 3: Pathophysiology 216
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 215
The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM 212
Coronary fistula of the left main artery draining in the right atrium and associated aorto-right atrial fistula 211
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 211
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 210
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry 205
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 205
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 200
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 200
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 199
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 196
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 196
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 195
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 189
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 188
Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy 178
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 176
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine 175
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 172
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 169
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 169
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation 168
Dilated cardiomyopathy: Dilated cardiomyopathy: Clinical assessment and differential diagnosis 167
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 166
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences 164
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 163
Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 162
Prognostic significance of longitudinal strain in dilated cardiomyopathy with recovered ejection fraction 162
Does extracorporeal cardiopulmonary resuscitation improve survival with favorable neurological outcome in out-of-hospital cardiac arrest? A systematic review and meta-analysis 157
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy 157
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 157
Effect of prehospital treatment in STEMI patients undergoing primary PCI 156
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 151
Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19 148
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 147
Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction 147
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 146
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 146
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 146
Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy 145
Using marginal structural joint models to estimate the effect of a time-varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy 142
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome 142
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 142
Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. 140
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 140
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 138
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients 136
Association of Premature Ventricular Contraction Burden on Serial Holter Monitoring with Arrhythmic Risk in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy 133
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 131
Risk of sudden cardiac death in New York Heart Association class I patients with dilated cardiomyopathy: A competing risk analysis 131
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator 130
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 129
The Arrhythmic Phenotype in Cardiomyopathy 128
Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications 127
Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives 126
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child 125
Impact of malnutrition in patients with severe heart failure 123
Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications 121
null 121
In-hospital evolution of secondary mitral regurgitation in acutely decompensated heart failure 120
Totale 22.029
Categoria #
all - tutte 74.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021381 0 0 0 0 0 0 0 0 0 177 84 120
2021/20221.352 67 82 67 75 85 125 63 43 137 142 136 330
2022/20233.242 188 291 294 420 270 415 151 291 314 150 287 171
2023/20242.484 204 161 169 220 213 266 390 303 63 108 242 145
2024/20254.565 113 207 385 397 406 354 233 262 577 674 446 511
2025/20269.699 1.090 672 807 1.073 956 884 1.413 416 1.167 1.221 0 0
Totale 26.561